COMP <GO>
HROW vs JNJ // RETURN ON INVESTED CAPITAL (ROIC)
Harrow Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: HROW 4
— JNJ 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: HROW
LAST: $29.99 (+2.04%) • MKT CAP: $1.12B
roic
42.90%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
roic
25.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HROW VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HROW | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.10% | 67.90% | +7.20 | HROW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 42.90% | 25.50% | +17.40 | HROW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.6x | 18.5x | +15.10 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 3.82% | 2.97% | +0.85 | HROW | /fcf-yield <GO> |
| Operating Margin | 11.20% | 34.70% | -23.50 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -1.90% | 28.50% | -30.40 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 36.40% | 6.00% | +30.40 | HROW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.67 | 5.59 | -2.92 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.5 | 62.1 | -23.56 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.12B | $662.49B | -$661.37B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HROW REV | JNJ REV | HROW GROSS % | JNJ GROSS % | HROW FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $272.3M | $94.19B | 75.1% | 67.9% | $43.0M | $19.70B |
| FY 2024 | $199.6M | $88.82B | 75.3% | 69.1% | -$23.8M | $19.84B |
| FY 2023 | $130.2M | $85.16B | — | — | $3.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HROW // BETA —
JNJ // BETA 1.08